Global Pernicious Anemia Market Research and Forecast, 2018-2023
Pernicious anemia is a disease in which the formation of red blood cells becomes slow due to deficiency of vitamin B-12 in the human body. The prime cause behind the disease is an autoimmune disorder in which the antibody released by immune system harms the intrinsic factor present in the stomach. The intrinsic factors play a vital role in the absorption of vitamin B-12 from the food. The deficiency of B-12 leads to a shortage of red blood cells in the bloodstream thereby leading to carry less oxygen to the blood. The elderly people are more prone to such disease. The increasing prevalence of autoimmune condition or intestinal diseases is the major motivating factor for the growth of the global pernicious anemia market. Moreover, effective medication techniques for treating autoimmune disorders also accounts for the growth of the market. The lack of awareness about the treatment of disease and the high cost of the drug is the major factors restraining the growth of the market. The supportive government regulations and increased expenditure for the development of healthcare infrastructure will create more rooms for future growth of the market. Moreover, the rapid research and development in the field of novel methods for treatment will also help in increasing the market across the globe
The market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is expected to hold a significant share in the pernicious anemia market attributed to a large number of geriatric populations. Moreover, the North American region also has tremendous potential in their healthcare facilities for such diseases. The Asia-Pacific region will grow significantly during the forecast period due to rapid development in the economies and large investment in the healthcare sector. The European region also holds a substantial share in the pernicious anemia market.
The competition in pernicious anemia market is moderate as the companies present in the market is not so active. The market players are engaged in providing various B-12 vitamin injections, sprays, immunosuppressant drugs and tests for Intrinsic factor deficiency. The key players in the pernicious anemia market are AMAG Pharmaceuticals, Inc., American Regen, Inc., Daiichi Sankyo Co, Ltd., Emisphere Technologies, Inc, and so on. The companies are engaged in rapid research and development for the development of effective treatment measure for the disease.
RESEARCH METHODOLOGY
The market study of global pernicious anemia market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
MARKET SEGMENTATION
Global pernicious anemia market is segmented on the basis of various regions and below mentioned segments.
1. Global Pernicious Anemia Market Research and Analysis by Diagnosis
2. Global Pernicious Anemia Market Research and Analysis by Treatment
3. Global Pernicious Anemia Market Research and Analysis by End-User
The report covers
The market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is expected to hold a significant share in the pernicious anemia market attributed to a large number of geriatric populations. Moreover, the North American region also has tremendous potential in their healthcare facilities for such diseases. The Asia-Pacific region will grow significantly during the forecast period due to rapid development in the economies and large investment in the healthcare sector. The European region also holds a substantial share in the pernicious anemia market.
The competition in pernicious anemia market is moderate as the companies present in the market is not so active. The market players are engaged in providing various B-12 vitamin injections, sprays, immunosuppressant drugs and tests for Intrinsic factor deficiency. The key players in the pernicious anemia market are AMAG Pharmaceuticals, Inc., American Regen, Inc., Daiichi Sankyo Co, Ltd., Emisphere Technologies, Inc, and so on. The companies are engaged in rapid research and development for the development of effective treatment measure for the disease.
RESEARCH METHODOLOGY
The market study of global pernicious anemia market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market
- Authentic Public Databases (org, gov and other such websites)
- Whitepapers such as research papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION
Global pernicious anemia market is segmented on the basis of various regions and below mentioned segments.
1. Global Pernicious Anemia Market Research and Analysis by Diagnosis
2. Global Pernicious Anemia Market Research and Analysis by Treatment
3. Global Pernicious Anemia Market Research and Analysis by End-User
The report covers
- Comprehensive research methodology of the global pernicious anemia market
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global pernicious anemia
- Insights about market determinants which are stimulating the global pernicious anemia
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulation
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Prevalence of Autoimmune Condition or Intestinal Diseases
3.1.2. Improving Healthcare Infrastructure
3.1.3. Availability of Effective Medications for Autoimmune Disorders
3.1.4. Vitamin Deficient Diet Intake
3.2. Restraints
3.2.1. Lack of Awareness About the Disease and Treatment
3.2.2. High Cost of Drugs
3.3. Opportunities
3.3.1. R&D in Development of Novel Methods for Treatment
4. MARKET SEGMENTATION
4.1. Global Pernicious Anemia Market by Diagnosis
4.1.1. Complete Blood Count Test
4.1.2. Vitamin B-12 Deficiency Test
4.1.3. Biopsy
4.1.4. Intrinsic Factor Deficiency Test
4.2. Global Pernicious Anemia Market by Treatment
4.2.1. Vitamin B-12 Injections
4.2.2. Vitamin B-12 Pills
4.3. Global Pernicious Anemia Market by End-User
4.3.1. Hospitals
4.3.2. Diagnostic Centers and Clinics
4.3.3. Homecare
5. COMPETITIVE LANDSCAPE
5.1. Key Strategies
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Alfasigma USA, Inc.
7.2. AMAG Pharmaceuticals, Inc.
7.3. American Regent, Inc.
7.4. BBI Group Holding Ltd.
7.5. Bio-Rad Laboratories, Inc.
7.6. BioVision, Inc.
7.7. Cleveland HeartLab, Inc.
7.8. Daiichi Sankyo Co., Ltd.
7.9. Emisphere Technologies, Inc.
7.10. Endo Pharmaceuticals, Inc.
7.11. GlaxoSmithKline, PLC
7.12. Koninklijke DSM N.V.
7.13. Laboratory Corporation of America Holdings
7.14. Medline Industries, Inc.
7.15. Merck KGaA
7.16. Monobind, Inc.
7.17. Pfizer, Inc.
7.18. Pharmacosmos A/S
7.19. Pharmavite, LLC
7.20. Premier Research Labs
7.21. Swanson Health Products
7.22. Takeda Pharmaceutical Co., Ltd.
7.23. The Synergy Company
7.24. Trinity Biotech PLC
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulation
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Prevalence of Autoimmune Condition or Intestinal Diseases
3.1.2. Improving Healthcare Infrastructure
3.1.3. Availability of Effective Medications for Autoimmune Disorders
3.1.4. Vitamin Deficient Diet Intake
3.2. Restraints
3.2.1. Lack of Awareness About the Disease and Treatment
3.2.2. High Cost of Drugs
3.3. Opportunities
3.3.1. R&D in Development of Novel Methods for Treatment
4. MARKET SEGMENTATION
4.1. Global Pernicious Anemia Market by Diagnosis
4.1.1. Complete Blood Count Test
4.1.2. Vitamin B-12 Deficiency Test
4.1.3. Biopsy
4.1.4. Intrinsic Factor Deficiency Test
4.2. Global Pernicious Anemia Market by Treatment
4.2.1. Vitamin B-12 Injections
4.2.2. Vitamin B-12 Pills
4.3. Global Pernicious Anemia Market by End-User
4.3.1. Hospitals
4.3.2. Diagnostic Centers and Clinics
4.3.3. Homecare
5. COMPETITIVE LANDSCAPE
5.1. Key Strategies
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Alfasigma USA, Inc.
7.2. AMAG Pharmaceuticals, Inc.
7.3. American Regent, Inc.
7.4. BBI Group Holding Ltd.
7.5. Bio-Rad Laboratories, Inc.
7.6. BioVision, Inc.
7.7. Cleveland HeartLab, Inc.
7.8. Daiichi Sankyo Co., Ltd.
7.9. Emisphere Technologies, Inc.
7.10. Endo Pharmaceuticals, Inc.
7.11. GlaxoSmithKline, PLC
7.12. Koninklijke DSM N.V.
7.13. Laboratory Corporation of America Holdings
7.14. Medline Industries, Inc.
7.15. Merck KGaA
7.16. Monobind, Inc.
7.17. Pfizer, Inc.
7.18. Pharmacosmos A/S
7.19. Pharmavite, LLC
7.20. Premier Research Labs
7.21. Swanson Health Products
7.22. Takeda Pharmaceutical Co., Ltd.
7.23. The Synergy Company
7.24. Trinity Biotech PLC
LIST OF TABLES
TABLE # 1 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 2 GLOBAL COMPLETE BLOOD COUNT TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL VITAMIN B-12 INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL VITAMIN B-12 PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL DIAGNOSTIC CENTERS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 18 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 19 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 20 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 21 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 25 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 27 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 28 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 2 GLOBAL COMPLETE BLOOD COUNT TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL VITAMIN B-12 INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL VITAMIN B-12 PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL DIAGNOSTIC CENTERS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 18 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 19 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 20 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 21 EUROPEAN PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 25 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 27 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 28 REST OF THE WORLD PERNICIOUS ANEMIA MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY DIAGNOSIS, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY TREATMENT, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY END-USER, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 NORTH AMERICA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 US PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 CANADA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 EUROPE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 UK PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 FRANCE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ITALY PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 REST OF EUROPE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 INDIA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 CHINA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 JAPAN PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF ASIA-PACIFIC PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 20 REST OF THE WORLD PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY DIAGNOSIS, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY TREATMENT, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY END-USER, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL PERNICIOUS ANEMIA MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 NORTH AMERICA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 US PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 CANADA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 EUROPE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 UK PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 FRANCE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ITALY PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 REST OF EUROPE PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 ASIA-PACIFIC PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 INDIA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 CHINA PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 JAPAN PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF ASIA-PACIFIC PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 20 REST OF THE WORLD PERNICIOUS ANEMIA MARKET SIZE, 2017-2023 ($ MILLION)
